The panel’s recommendation is the result of new information from the government’s Food and Drug Administration (FDA) on rare but serious cases of thrombosis. By August 31, at least 54 people – mostly young and middle-aged women – vaccinated with J&J required hospitalization due to this problem. Nine of these people died.
Blood clots in April prompted J&J vaccination to be suspended for 10 days, but government agencies ultimately ruled that the benefits of vaccination outweigh its risks.
According to CDC experts, vaccines using mRNA technology – produced by Moderna and Pfizer / BioNTech companies – offer better protection and lower risk. This opinion is not binding, and the J&J vaccine will continue to be available to Americans. So far, over 16 million people have chosen it.
We are glad that you are with us. Subscribe to the Onet newsletter to receive the most valuable content from us
–
